4//SEC Filing
Jerel Davis 4
Accession 0001415889-25-021338
CIK 0001764974other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:06 PM ET
Size
14.7 KB
Accession
0001415889-25-021338
Insider Transaction Report
Form 4
Jerel Davis
Director
Transactions
- Disposition from Tender
Common Stock
2025-08-08−2,726,322→ 0 total(indirect: By Versant Venture Capital V, L.P.) - Disposition from Tender
Common Stock
2025-08-08−90,888→ 0 total(indirect: By Versant Ophthalmic Affiliates Fund I, L.P.) - Disposition from Tender
Common Stock
2025-08-08−207,486→ 0 total(indirect: By Versant Venture Capital V (Canada) LP) - Disposition from Tender
Common Stock
2025-08-08−82,006→ 0 total(indirect: By Versant Affiliates Fund V, L.P.) - Disposition from Tender
Common Stock
2025-08-08−274,990→ 0 total(indirect: By Versant Vantage II, L.P.)
Footnotes (6)
- [F1]Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation ("Purchaser") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest.
- [F2]Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP") is the sole general partner of Vantage II GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein.
- [F3]Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. The Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of his respective pecuniary interest therein.
- [F4]Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. The Reporting Person, a member of the Issuer's board of directors, is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein.
- [F5]Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. The Reporting Person disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of his respective pecuniary interest therein.
- [F6]Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. The Reporting Person disclaims beneficial ownership of the shares held by Affiliates, except to the extent of his respective pecuniary interest therein.
Documents
Issuer
Turnstone Biologics Corp.
CIK 0001764974
Entity typeother
Related Parties
1- filerCIK 0001745958
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:06 PM ET
- Size
- 14.7 KB